T. Pedrazzin, F. Pralong, E. Grouzmann (2003). Neuropeptide Y: the universal soldier. Cell. Mol.
Life Sci. 60: 350–377.
L. Protas, J. Qu, R. B. Robinson (2003). Neuropeptide Y: neurotransmitter or trophic factor in the
heart?News Physiol. Sci. 18 : 181–185.
B. F. B. Sandberg, L. L. Iversen (1982). Substance P. J. Med. Chem. 25: 1009–1015.
J. Saunders, J. P. Williams (2001). New developments in the study of corticotropin releasing
factor. Ann. Rep. Med. Chem. 36: 21–29.
A. W. Stamford, E. M. Parker (1999). Recent advances in the development of neuropeptide Y
receptor antagonists. Ann. Rep. Med. Chem. 34: 31–39.
A. W. Stamford, J. Hwa, M. van Heek (2003). Recent developments in neuropeptide Y receptor
modulators.Ann. Rep. Med. Chem. 38: 61.
C. Swain, N. M. J. Rupniak (1999). Progress in the development of neurokinin antagonists.
Ann. Rep. Med. Chem. 34: 51–60.
Neuromodulators:Taurine
M. Galarreta, J. Bustamante, R. M. Del Rio, J. M. Solis (1996). A new neuromodulatory
action of taurine: long-lasting increase of synaptic potentials. Adv. Exp. Med. Biol. 403 :
463–471.
R. I. Huxtable, L. A. Sebring (1986). Towards a unifying theory for the action of taurine. Trends
Pharmacol. Sci. 7: 481–485.
S. S. Oja, P. Saransaari (1996). Taurine as osmoregulator and neuromodulator in the brain.
Metabol. Brain Dis. 11: 153–164.
M. F. Olive (2002). Interactions between taurine and ethanol in the central nervous system. Amino
Acids 23: 345–357.
P. Saransaari, S. S. Oja (2000). Taurine and neural cell damage. Amino Acids 19: 509–526.
C. E. Wright, H. H. Tallan, Y. Y. Lin, G. E. Gault (1986). Taurine: biological update. Annu. Rev.
Biochem. 55: 427–453.
Neuromodulators:Purines
G. Burnstock (1983). Purinergic Receptors. London: Chapman and Hall.
J. R. Cooper, F. E. Bloom, R. R. Roth (1986). The Biochemical BasisofNeuropharmacology,
5th ed. New York: Oxford University Press.
J. W. Daly (1985). A 3 Adenosine receptors. Adv. Cyclic Nucleotide Res. 18: 29–46.
A. Dobolyi, A. Reichart, T. Szikra, G. Juhasz (1998). Purine and pyrimidine nucleoside content
of the neuronal extracellular space in rat: An in vivomicrodialysis study. Adv. Exp. Med. Biol.
431 : 83–87.
B. B. Fredholm, B. Johansson, I. van der Ploeg, P. S. Hu, S. Jin (1993). Neuromodulatory roles
of purines. Drug Dev. Res. 28 : 349–353.
K. A. Jacobson (2002). Purine and pyrimidine neucleotide (P2) receptors. Ann. Rep. Med. Chem.
37 : 75.
K. A. Jacobson, S. Tchilibon, B. V. Joshi, Z.-G. Gao (2003). Ann. Rep. Med. Chem. 38: 121.
T. Katsuragi, T. Furukawa (1985). Novel, selective purinoceptor antagonists: investigation of ATP
as a neurotransmitter. Trends Pharmacol. Sci. 6: 337–339.
D. Satchell (1984). Purine receptors: classification and properties. Trends Pharmacol. Sci. 5:
340–343.
S. H. Snyder (1985). Adenosine as a neuromodulator. Annu. Rev. Neurosci. 8: 103–124.
G. L. Stiles (1986). Adenosine receptors: structure, function and regulation. Trends Pharmacol.
Sci. 7: 486–490.
NEUROTRANSMITTERS AND THEIR RECEPTORS 309